HIM
THTX

Hillsdale Investment Management’s Theratechnologies THTX Stock Holding History

Hillsdale Investment Management’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-59,578
Closed -$108K – 706
2024
Q4 		$108K Buy
+59,578
New +$81K 0.01% 432

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hillsdale Investment Management's THTX Position: Q1 2025 in Review

Hillsdale Investment Management sold out of Theratechnologies (THTX) in Q1 2025, closing a stake of 59,578 shares — an estimated $108K sold.

Hillsdale Investment Management first reported a position in THTX in Q4 2024 and held it in 1 quarter. The position peaked at $108K in Q4 2024. 39 funds tracked by Wall St. Rank hold THTX as of Q1 2025.

  • Hillsdale Investment Management reported no remaining Theratechnologies position as of Q1 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 59,578 Theratechnologies shares in Q1 2025, an estimated $108K.
  • Hillsdale Investment Management first reported a position in Theratechnologies in Q4 2024 and held it in 1 quarter.
  • Hillsdale Investment Management's Theratechnologies position peaked at $108K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Theratechnologies as of Q1 2025.

Based on Hillsdale Investment Management's 13F filing for Q1 2025, filed 9 May 2025.